Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling

Hemophilia patients could have an easier time taking their medication if the U.S. Food and Drug Administration (FDA) gives the green light for the newest formulation of Genentech’s Hemlibra.